96899 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
Sub-classes:PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS
#2ERYTHROCYTE-BINDING THERAPEUTICS
#3PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS
#4Erythrocyte-binding therapeutics
#5Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#6Erythrocyte-binding therapeutics
#7Cell-based assay for determining mTOR activity
#8SOLID PHASE PEPTIDE SYNTHESIS
#9Solid phase peptide synthesis
#10Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#11Erythrocyte-binding therapeutics
#12Nuclear factor-erythroid 2 related factor 2 (NRF2) biosensors and modulators of NRF2
#13Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#14Methods of Treating Glucose Metabolism Disorders
#15Erythrocyte-binding therapeutics